SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001558370-22-002816
Filing Date
2022-03-03
Accepted
2022-03-03 16:35:34
Documents
6
Effectiveness Date
2022-03-03

Document Format Files

Seq Description Document Type Size
1 S-8 tmb-20220303xs8.htm S-8 90707
2 EX-5.1 tmb-20220303xex5d1.htm EX-5.1 7870
3 EX-23.1 tmb-20220303xex23d1.htm EX-23.1 4299
4 EX-FILING FEES tmb-20220303xexfilingfees.htm EX-FILING FEES 21815
5 GRAPHIC tmb-20220303xex5d1001.jpg GRAPHIC 13207
6 GRAPHIC tmb-20220303xex5d1002.jpg GRAPHIC 9804
  Complete submission text file 0001558370-22-002816.txt   157779
Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Filer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263266 | Film No.: 22709506
SIC: 2834 Pharmaceutical Preparations